Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Expensive Performer
241.1600 0.53 (0.22%)
NSE May 09, 2025 15:31 PM
Volume: 38,062
 

241.16
0.22%
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
BSE India
In compliance with the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of the Directors of the Company at their meeting held on June 5, 2023, approved the acquisition of 85% equity stake in FPP Holding Company, LLC ('FPP Holding'), a company registered in Delaware, USA ('Acquisition'). Consequently, Indoco Remedies Limited ('Company') has executed Equity Purchase Agreement on June 5, 2023 for the Acquisition. Please find enclosed a press release in this regard and details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFO/CMD/4/2015 dated September 9, 2015 in Annexure 'A' and 'B'.
More from Indoco Remedies Ltd.
Recommended